Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital

Anticancer Research

Volumn 16, Issue 3 A, 1996, Pages 1265-1268

  Huncharek, Michael ^a   Kelsey, Karl ^b   Mark, Eugene J ^a   Muscat, Joshua ^c   Choi, Noah ^a   Carey, Robert ^a   Christiani, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Asbestos; Chemotherapy; Combined modality; Surgery; Survival

Indexed keywords

5,6 DIHYDROAZACITIDINE; ANTINEOPLASTIC AGENT; ASBESTOS; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0029975748     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Antman K: Current concepts, malignant mesothelioma. N Engl J Med 303: 200-202, 1980.
2. Huncharek M: Changing risk groups for malignant mesothelioma. Cancer 69: 2704-2711, 1992.
3. McDonald JC. Health implications of environmental exposure to asbestos. Envir Health Persp 62: 319-328, 1985.
4. Pass H, Pogrebniak HW. Malignant pleural mesothelioma. Curr Prob Surg 30(10): 932-1013, 1993.
5. Ferguson DA, Berry G, Jelihovsky T et al: The Australian mesothelioma surveillance program, 1979-1985. Med J Aust 147. 166-172, 1987.
6. Andersson M, Olsen JH. Trends and distribution of mesothelioma in Denmark. Br J Cancer 51: 699-705, 1985.
7. Churg A. Malignant mesothelioma in British Columbia. Cancer 55: 672-674, 1985.
8. Ruffie P, Minkin FS, Cormier Y et al: Diffuse malignant mesothelioma of the pleural in Ontatio and Quebec; A retrospective study of 332 patients. J Clin Onol 7: 1157-1168, 1989.
9. Law MR, Gregor A, Hodson ME et al: Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 39. 255-259, 1984.
10. Antman K, Shemin R, Ryan L et al: Malignant mesothelioma: Prognostic variaables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 6(1): 147-153, 1988.
11. Chailleux E, Dabouis G, Pioche D et al: Prognostic factors in diffuse malignant pleural mesothelioma; A study of 167 patients. Chest 93(1):159-162, 1988.